Anemia management for home dialysis including the new US public policy initiative
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Kidney International Supplements
- Vol. 11 (1) , 59-69
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 129 references indexed in Scilit:
- Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristicsBMC Nephrology, 2013
- Survival in Daily Home Hemodialysis and Matched Thrice-Weekly In-Center Hemodialysis PatientsJournal of the American Society of Nephrology, 2012
- Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in CanadaNephrology Dialysis Transplantation, 2012
- Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney diseaseCanadian Medical Association Journal, 2012
- Correction of Postkidney Transplant Anemia Reduces Progression of Allograft NephropathyJournal of the American Society of Nephrology, 2012
- Home Hemodialysis and Mortality Risk in Australian and New Zealand PopulationsAmerican Journal of Kidney Diseases, 2011
- The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialKidney International, 2011
- Long Interdialytic Interval and Mortality among Patients Receiving HemodialysisNew England Journal of Medicine, 2011
- In-Center Hemodialysis Six Times per Week versus Three Times per WeekNew England Journal of Medicine, 2010
- Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of LifeJAMA, 2007